2006
DOI: 10.1016/j.juro.2006.07.013
|View full text |Cite
|
Sign up to set email alerts
|

Preliminary Results of Sacral Neuromodulation in 23 Children

Abstract: Sacral nerve stimulation in children is an option for carefully selected patients who have failed other therapies. Our results show that sacral nerve stimulation was effective in the majority of patients with the dysfunctional elimination syndrome. However, longer followup is needed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
71
0
2

Year Published

2011
2011
2018
2018

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 89 publications
(79 citation statements)
references
References 15 publications
1
71
0
2
Order By: Relevance
“…3 Bladder capacity evaluated by UDS was significantly different between neurogenic and nonneurogenic patients both initially (p < 0.0001) and after (p = 0.008) treatment with anticholinergic combination therapy. 4 Amplitude of detrusor contractions on UDS were significantly decreased by combination treatment; overall, neurogenic and non-neurogenic groups (p < 0.0001).…”
Section: Resultsmentioning
confidence: 88%
See 2 more Smart Citations
“…3 Bladder capacity evaluated by UDS was significantly different between neurogenic and nonneurogenic patients both initially (p < 0.0001) and after (p = 0.008) treatment with anticholinergic combination therapy. 4 Amplitude of detrusor contractions on UDS were significantly decreased by combination treatment; overall, neurogenic and non-neurogenic groups (p < 0.0001).…”
Section: Resultsmentioning
confidence: 88%
“…3 Introduction of the second anticholinergic medication. 4 If tolterodine ER 4 mg was not well tolerated as a second anticholinergic medication, it was discontinued and changed for solifenacin 5 mg. 5 If solifenacin was not well-tolerated, it was discontinued and alternative treatment was offered. Addition of medication; : change of medication.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Based on our experience and current literature, SNM should only be considered in children who have failed an extended period of behavioral modification, biofeedback, and pharmacologic therapy [9][10][11][12][13][14][15]. Several groups have also offered intravesical botulinum toxin A, transcutaneous electrical nerve stimulation, and percutaneous tibial nerve stimulation to this population of children but have not required them to fail these less invasive therapies prior to SNM [13,15].…”
Section: Indicationsmentioning
confidence: 99%
“…Several groups have excluded children with neurologic diseases or spinal deformities in their series [10,11,14,15]. Significant spinal deformities may complicate or even prohibit lead placement in the foramen of the third sacral spinal nerve (S3).…”
Section: Indicationsmentioning
confidence: 99%